Home > Resources > Infographics > Mallinckrodt is ‘United for Patient Safety’ for Patient Safety Awareness Week March 13-19

Mallinckrodt is ‘United for Patient Safety’ for Patient Safety Awareness Week March 13-19

March 7, 2016

Work is being done at the federal, state and local levels to support safer care, but it takes all of us within the care continuum to stand united. There is still so much more that can be done.

Spotlight

Lifecare Innovations Private Limited

Lifecare Innovations is a R&D intensive company specialised in controlled release pharmaceuticals employing an array of technologies of novel drug delivery systems. The first product is a Liposome mediated delivery of Amphotericin B to target fungal or leishmania cells. Lifecare Innovations received Technology Day 2004 National Award for Bio-technology in recognition of the indigenous development and production of life saving drug - FUNGISOME. The award function was presided by His Excellency the President of India Dr. A.P.J. Abdul Kalam. The award and the citation were presented by the Minister of Science Technology and Ocean Development Mr. Kapil Sibbal. Lifecare Innovations is engaged in the development of number of other controlled release drugs in collaboration with national institutions. These are under various stages of development. Predominant among these are a range of anti-fungals. To complement anti-fungal treatment, Lifecare Innovations has also launched Itraconazole capsul

Other Infographics

Taking Pharmacy Benefits on a New Ride

Infographic | December 1, 2019

Rideshare companies like Uber and Lyft challenged the old way of doing things with a new approach. It’s not just about getting from point A to point B anymore, it’s about the experience, convenience and added value. The same applies to pass-through PBMs (pharmacy benefit managers) that are challenging the status quo to make prescriptions more affordable..

Pharma Technology Focus

Infographic | June 3, 2022

Pharma Technology Focus is free to read on all devices.

Smart Pharmacovigilance

Infographic | May 23, 2021

Pharmacovigilance (PV) is essential to all life science organizations, ensuring that patients' health comes first. Various trends in global healthcare have transformed today’s PV function into a corporate asset that enhances brand value and contributes to new growth opportunities. However, existing safety systems impose a significant cost burden to operate.

Summary of Chloroquine and Hydroxychloroquine Drug-Drug Interactions

Infographic | April 7, 2020

COVID-19 is a rapidly emerging and devastating pandemic disease. Recently, chloroquine (CQ) and hydroxychloroquine (HCQ) have been suggested for possible off-label use for patients suffering from a more severe clinical course.

Cancer Drugs Bring in Most Pharma Revenue

Infographic | February 25, 2020

Worldwide cancer drug sales are already way ahead of those of other drugs and the revenue generated by them is expected to grow even larger by 2024. This is according to a report recently released by consultancy Evaluate, which analyses trends in the pharmaceutical sector. According to Evaluate's calculations, oncology drugs reached US$123.8 billion in sales in 2018, more than double that of the next item on the list, drugs treating diabetes with US$48.5 billion dollars in sales. By 2024, cancer drug sales are expected to almost double to US$236.6 billion dollars.

Do patients actually watch all those pharma TV ads?

Infographic | January 13, 2020

Fewer than one in eight chronic-disease sufferers say they watch when a drug commercial comes on TV, according to one recent study of community users. And for the millennials among them, the percentage is even less so. That’s despite the $5.1 billion spent by biopharma on the medium in 2018. We take a look at these data points and many others from two recent studies on the media habits of patients and doctors.

Mallinckrodt is ‘United for Patient Safety’ for Patient Safety Awareness Week March 13-19